Safety and Efficacy of Evolocumab in Ischemic Stroke

NCT05697185 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke, Acute

Interventions

DRUG: Evolocumab

Sponsor

Second Affiliated Hospital of Guangxi Medical University